COVID-19 Resources Page

COVID-19 is forcing a change in how we do research.

Valis has prepared a resource to support understanding how the pandemic will affect the research landscape, and what can be done.

The resource covers:

  • Research interruptions due to flattening of coronavirus curve

  • Non-invasive monitoring devices

  • Remote monitoring

  • Remote and virtual assessment options

 

Our Response to COVID-19

Valis is committed to stopping the spread of the novel Coronavirus (COVID-19) and supporting our customers during the current global pandemic. We are dedicated to maintaining the continuity of research procedures and ensuring the safety of all research participants, families, and investigative sites. To do so, we have put in place the following protective measures:

  • Remote work for all employees

  • Suspension of employee travel

  • Implementation of our robust business continuity plan

  • Daily meetings to assess coronavirus-related developments

  • Outreach to existing customers regarding considerations for scientific alternatives to face-to-face assessments

  • Services and support for psychometric assessment administration and site staff education

For individuals and Sponsors on the forefront of COVID-19 vaccine development, we are offering abrupt and discounted access to our services and eLearning platform. We look forward to working with and helping our customers and clinical trials research investigators in the life sciences industry during this unprecedented time.

       Christian Yavorsky

       Chief Scientific Officer, Valis Bioscience

 
 
Contact VALIS
ContaCT SUPPORT:
HELP@VALISBIOSCIENCE.com

Valis has locations in San Francisco, CA,  Berkeley CA, and New York, NY.

Valis Biosciences, Inc.

2111 San Pablo Ave

PO Box 2054

Berkeley California, 94702

  • LinkedIn Social Icon
  • Black Facebook Icon
  • Black Twitter Icon
General Inquiries:

© 2020 @ Valis Biosciences Inc. All rights reserved.